[7] In STEP-4 (N=803), participants who continued semaglutide after a 20-week run-in maintained or further reduced their weight, while those who switched to placebo regained 6.9 percentage points of body weight by week 68
Doi: The study reports the results of a newer pharmacologic agent for gastroparesis of which larger studies are in process
Patients may consider switching from Mounjaro (Tirzepatide) to Wegovy (Semaglutide) for: Price increase of Mounjaro (expected hike up to 170%) may make Wegovy more accessible Monitor for side effects like nausea, vomiting, or appetite changes
1 More About Hormones and Headaches Neurological and endocrine studies have shown that estrogen seems to modulate the severity and frequency of migraines
By sharing outcomes, questioning what we've always done, and truly listening to our patients and providers, we can make these programs even better
It is also worth noting that glucagon receptor activation can raise heart rate and plasma glucose